T1	Outcomes 449 474	progression-free survival
T2	Outcomes 847 872	progression-free survival
T3	Outcomes 1041 1049	survival
T4	Outcomes 1187 1317	account disease extent, maintenance therapy, Karnofsky performance status (PS), and absolute dose-intensity (ADI) of anthracycline
T5	Outcomes 1342 1378	limited disease (LD) and maintenance
T6	Outcomes 1431 1440	survival.
